Transplantation Market Size To Hit USD 33.7 Bn By 2032

The global transplantation market size accounted for USD 15.1 billion in 2022 and is expected to reach around USD 33.7 billion by 2032, growing at a CAGR of 8.36% from 2023 to 2032.

Key Takeaways

North America led the global market with the highest market share of 42% in 2022.
Asia-Pacific is anticipated to expand at the fastest CAGR during the forecast period.
By Product Type, the tissue products segment has held the maximum revenue share of 59% in 2022.
By Product Type, the immunosuppressive drugs segment is anticipated to grow at a remarkable CAGR during the projected period.
By Application, the tissue transplantation segment had the major market share of 62% in 2022.
By Application, the organ transplantation segment is estimated to expand at the fastest CAGR over the projected period.
By End-use, the hospitals segment held the major revenue share of 49.5% in 2022.
By End-use, the transplant centers segment is anticipated to grow at the fastest CAGR during the projected period.

Organ transplantation is one of the major advancement in the modern day medicine. It is a medical procedure in which missing or damaged organ of one body is replace from the organ of another body. One of the prime aspects in organ transplantation is the consent of patient or any family member, without so it is considered as illegal or a crime. The organ transplantation is most processed when the brain of the patient is dead and other body organs are healthy. This process of organ transplantation should be done right after the patient’s death within couple of hours. This is very beneficial for the treatment of failed organs such as lungs, kidney, liver, and many more. Kidney transplantation is most widely procedure followed by liver transplantation. However, the number of organ donors are quite less compared to the patients those require transplantation. As per National Kidney Foundation, every month more than 3,000 new patients are added to the list of kidney waiting patients worldwide.

Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1047

Regional Snapshots

In 2019, North America emerged as the global leader in the transplantation market with revenue share of around 40%. Rapid development in the medical sector along with rising prevalence of organ failure triggers the growth of the region in the global market. In addition, high healthcare expenditure coupled with well-developed healthcare sector is the prime factors contributing to the prominent growth of the region.

On the other hand, the Asia Pacific encountered the rapid growth rate during the forecast period owing to rising investment on healthcare sector along with significant government initiatives towards creating awareness among the people for organ donation. Additionally, rising number of patient suffering from chronic disease are likely to boost the demand for tissue and organ transplantation.

Growth Factors

Increasing prevalence of chronic disease along with organ failure are the prime factors driving the transplantation market growth. Over consumption of alcohol & other harmful substances fuels along with unhealthy diet propel the market growth for organ transplantation. However, religious belief of people as well as lack of awareness for organ donation restricts the market growth. There is a huge gap between the demand for organ transplantation and the actually available donors.

Key Players & Strategies

The global transplantation market is highly fragmented due to the significant presence of all scale vendors that include small, medium, and large market players. Industry participants have their main focus on mergers & acquisitions, new product launch, and regional expansions to gain prominent traction in overall market revenue share. In addition, merger & acquisition help vendors to expand their geographical reach as well as product portfolio. For instance, in June 2015, Zimmer Holdings, Inc. acquired Biomet. The acquisition helped company to strengthen its distribution channel as well as product portfolio.

Some of the prominent players in the transplantation market include:

Arthrex, Inc.
Abbvie, Inc.
Teva Pharmaceuticals
Medtronic PLC
Zimmer Biomet
Strykers
Novartis AG
BiolifeSolutions, Inc.
21st Century Medicine
Veloxis Pharmaceutical

Segments Covered in the Report

By Product Type

Immunosuppressive Drugs
Tissue Products
Preservation Solution

By Application

Tissue Transplantation
Organ Transplantation

By End-use

Transplant Centers
Hospitals
Others

By Regional Outlook

North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
Asia Pacific
- China
- India
- Japan
- South Korea
Rest of the World

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Transplantation Market, By Product

7.1. Transplantation Market, by Product Type, 2023-2032
7.1.1. Immunosuppressive Drugs
7.1.1.1. Market Revenue and Forecast (2021-2032)
7.1.2. Tissue Products
7.1.2.1. Market Revenue and Forecast (2021-2032)
7.1.3. Preservation Solution
7.1.3.1. Market Revenue and Forecast (2021-2032)

Chapter 8. Global Transplantation Market, By Application

8.1. Transplantation Market, by Application, 2023-2032
8.1.1. Tissue Transplantation
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.2. Organ Transplantation
8.1.2.1. Market Revenue and Forecast (2021-2032)

Chapter 9. Global Transplantation Market, By End-use

9.1. Transplantation Market, by End-use, 2023-2032
9.1.1. Transplant Centers
9.1.1.1. Market Revenue and Forecast (2021-2032)
9.1.2. Hospitals
9.1.2.1. Market Revenue and Forecast (2021-2032)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2021-2032)

Chapter 10. Global Transplantation Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2021-2032)
10.1.2. Market Revenue and Forecast, by Application (2021-2032)
10.1.3. Market Revenue and Forecast, by End-use (2021-2032)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2021-2032)
10.1.4.2. Market Revenue and Forecast, by Application (2021-2032)
10.1.4.3. Market Revenue and Forecast, by End-use (2021-2032)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2021-2032)
10.1.5.2. Market Revenue and Forecast, by Application (2021-2032)
10.1.5.3. Market Revenue and Forecast, by End-use (2021-2032)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2021-2032)
10.2.2. Market Revenue and Forecast, by Application (2021-2032)
10.2.3. Market Revenue and Forecast, by End-use (2021-2032)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2021-2032)
10.2.4.2. Market Revenue and Forecast, by Application (2021-2032)
10.2.4.3. Market Revenue and Forecast, by End-use (2021-2032)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2021-2032)
10.2.5.2. Market Revenue and Forecast, by Application (2021-2032)
10.2.5.3. Market Revenue and Forecast, by End-use (2021-2032)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2021-2032)
10.2.6.2. Market Revenue and Forecast, by Application (2021-2032)
10.2.6.3. Market Revenue and Forecast, by End-use (2021-2032)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2021-2032)
10.2.7.2. Market Revenue and Forecast, by Application (2021-2032)
10.2.7.3. Market Revenue and Forecast, by End-use (2021-2032)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2021-2032)
10.3.2. Market Revenue and Forecast, by Application (2021-2032)
10.3.3. Market Revenue and Forecast, by End-use (2021-2032)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2021-2032)
10.3.4.2. Market Revenue and Forecast, by Application (2021-2032)
10.3.4.3. Market Revenue and Forecast, by End-use (2021-2032)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2021-2032)
10.3.5.2. Market Revenue and Forecast, by Application (2021-2032)
10.3.5.3. Market Revenue and Forecast, by End-use (2021-2032)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2021-2032)
10.3.6.2. Market Revenue and Forecast, by Application (2021-2032)
10.3.6.3. Market Revenue and Forecast, by End-use (2021-2032)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2021-2032)
10.3.7.2. Market Revenue and Forecast, by Application (2021-2032)
10.3.7.3. Market Revenue and Forecast, by End-use (2021-2032)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2021-2032)
10.4.2. Market Revenue and Forecast, by Application (2021-2032)
10.4.3. Market Revenue and Forecast, by End-use (2021-2032)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2021-2032)
10.4.4.2. Market Revenue and Forecast, by Application (2021-2032)
10.4.4.3. Market Revenue and Forecast, by End-use (2021-2032)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2021-2032)
10.4.5.2. Market Revenue and Forecast, by Application (2021-2032)
10.4.5.3. Market Revenue and Forecast, by End-use (2021-2032)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2021-2032)
10.4.6.2. Market Revenue and Forecast, by Application (2021-2032)
10.4.6.3. Market Revenue and Forecast, by End-use (2021-2032)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2021-2032)
10.4.7.2. Market Revenue and Forecast, by Application (2021-2032)
10.4.7.3. Market Revenue and Forecast, by End-use (2021-2032)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2021-2032)
10.5.2. Market Revenue and Forecast, by Application (2021-2032)
10.5.3. Market Revenue and Forecast, by End-use (2021-2032)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2021-2032)
10.5.4.2. Market Revenue and Forecast, by Application (2021-2032)
10.5.4.3. Market Revenue and Forecast, by End-use (2021-2032)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2021-2032)
10.5.5.2. Market Revenue and Forecast, by Application (2021-2032)
10.5.5.3. Market Revenue and Forecast, by End-use (2021-2032)

Chapter 11. Company Profiles

11.1. Arthrex, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Abbvie, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Teva Pharmaceuticals
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Medtronic PLC
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Zimmer Biomet
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Strykers
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Novartis AG
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. BiolifeSolutions, Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. 21st Century Medicine
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Veloxis Pharmaceutical
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives